Skip to main content

Table 2 Comparison of biochemical test indicators with fulminant myocarditis

From: Analysis of risk factors affecting prognosis of fulminant myocarditis in children: a ten-year single-center study

 

survival (n = 32)

non-survival (n = 8)

p

On admission

CK-MB (U/L)

101 (49.3, 109.5)

226.8 (57, 290.3)

0.06

cTnI (ug/L)

1.1 (0.5, 1.3)

2.1 (0.9, 3.4)

0.052

Scr (umol/L)

70.2 (37, 70)

120.1 (56.8, 182.8)

0.016

AST(U/L)

287.3 (89, 424.5)

941.6 (102, 2006.8)

0.12

ALT(U/L)

150.7 (25, 210)

711.8 (59.5, 1330.8)

0.31

Lactate (mmol/L)

4.8 (2.5, 6.4)

7 (4.1, 9.1)

0.048

NT-proBNP (pg/mL)

24,553.2(4282.5, 27328.8)

18,375.3 (5156.5, 34480.3)

0.477

Peak levels

CK-MB (U/L)

178 (50, 160.3)

1004.8 (264.8, 902.8)

< 0.001

cTnI (ug/L

1.8 (0.7, 2.3)

4.4 (2.0, 5.5)

0.006

Scr (umol/L)

93.8 (49, 86.5)

311.6 (122.8, 260.8)

< 0.001

AST(U/L)

914.4 (116, 1122.5)

4124 (1144, 4526.5)

0.003

ALT(U/L)

764.4 (47.5, 909.8)

2448.8 (347, 3764.3)

0.015

Lactate (mmol/L)

7.8 (4.8, 11)

13.6 (11.3, 15)

0.002

NT-proBNP (pg/mL)

19,856.1(9297.5, 34378.3)

30,211 (23460.5, 35000)

0.014

  1. CK-MB Creatine kinase isoenzyme, cTnI Cardiac troponin I, NT-proBNP N-terminal B-type natriuretic peptide precursor, Scr Serum creatinine, AST Aspartate aminotransferase, ALT Alanine aminotransferase